Man Group plc Makes New Investment in Acadia Healthcare Company, Inc. $ACHC

Man Group plc bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 255,147 shares of the company’s stock, valued at approximately $7,534,000. Man Group plc owned 0.27% of Acadia Healthcare as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. BlackRock Inc. purchased a new position in shares of Acadia Healthcare during the second quarter valued at approximately $441,685,000. Wellington Management Group LLP boosted its holdings in Acadia Healthcare by 24.9% in the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after purchasing an additional 2,350,760 shares during the last quarter. Goldman Sachs Group Inc. grew its position in Acadia Healthcare by 417.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the period. UBS Group AG raised its stake in Acadia Healthcare by 8.8% during the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock valued at $107,377,000 after buying an additional 350,484 shares during the last quarter. Finally, Jefferies Financial Group Inc. bought a new position in shares of Acadia Healthcare during the 4th quarter valued at $47,960,000.

Acadia Healthcare Stock Down 5.5%

ACHC stock opened at $28.55 on Friday. The business’s 50-day moving average price is $30.46 and its 200-day moving average price is $26.06. The stock has a market cap of $2.66 billion, a P/E ratio of -2.29, a PEG ratio of 9.20 and a beta of 0.64. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The company had revenue of $865.84 million for the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The firm’s revenue was down .4% compared to the same quarter last year. During the same quarter last year, the business earned $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

Analysts Set New Price Targets

Several analysts recently commented on the company. Royal Bank Of Canada lifted their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a report on Monday, May 4th. Jefferies Financial Group raised Acadia Healthcare from a “hold” rating to a “buy” rating and raised their target price for the stock from $24.50 to $30.00 in a research report on Wednesday, June 3rd. Barclays upped their price target on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research report on Thursday, July 30th. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a report on Monday, May 4th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Hold” and an average price target of $29.85.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.